Österberg, A.W.; Östman-Smith, I.; Green, H.; Gunnarsson, C.; Fredrikson, M.; Liuba, P.; Fernlund, E.
Biomarkers and Proteomics in Sarcomeric Hypertrophic Cardiomyopathy in the Young—FGF-21 Highly Associated with Overt Disease. J. Cardiovasc. Dev. Dis. 2024, 11, 105.
https://doi.org/10.3390/jcdd11040105
AMA Style
Österberg AW, Östman-Smith I, Green H, Gunnarsson C, Fredrikson M, Liuba P, Fernlund E.
Biomarkers and Proteomics in Sarcomeric Hypertrophic Cardiomyopathy in the Young—FGF-21 Highly Associated with Overt Disease. Journal of Cardiovascular Development and Disease. 2024; 11(4):105.
https://doi.org/10.3390/jcdd11040105
Chicago/Turabian Style
Österberg, Anna Wålinder, Ingegerd Östman-Smith, Henrik Green, Cecilia Gunnarsson, Mats Fredrikson, Petru Liuba, and Eva Fernlund.
2024. "Biomarkers and Proteomics in Sarcomeric Hypertrophic Cardiomyopathy in the Young—FGF-21 Highly Associated with Overt Disease" Journal of Cardiovascular Development and Disease 11, no. 4: 105.
https://doi.org/10.3390/jcdd11040105
APA Style
Österberg, A. W., Östman-Smith, I., Green, H., Gunnarsson, C., Fredrikson, M., Liuba, P., & Fernlund, E.
(2024). Biomarkers and Proteomics in Sarcomeric Hypertrophic Cardiomyopathy in the Young—FGF-21 Highly Associated with Overt Disease. Journal of Cardiovascular Development and Disease, 11(4), 105.
https://doi.org/10.3390/jcdd11040105